Tan Lab | DSigDB

Gene Set: D4 : CTD - Cyclophosphamide

Collection

D4 : CTD

Chemical Name

Cyclophosphamide ( From PubChem : CYCLOPHOSPHAMIDE )

FDA	NPC	WHO	Indian	Australia	China	Traditional Herbal	Clinical Trail
Approved	Not	Approved	Approved	Not	Approved	Not	Not

Molecular Weight	Hydrogen Bond Donor Count	Hydrogen Bond Acceptor Count	cLogP	Lipinski Rule
261.086 g/mol	1	4	2.2128	True

Structure

InChI

InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)/t14-/m1/s1

InChIKey

CMSMOCZEIVJLDB-CQSZACIVSA-N

Links

Gene (280 / 441)

⊖ Less

Source	Type	Unit	Value	Gene	PMID	Other
CTD	affects(cotreatment)			ABCB1		D003520
CTD	affects(response to substance)			ABCB1		D003520
CTD	increases(activity)			ABCB1		D003520
CTD	increases(expression)			ABCB1		D003520
CTD	increases(reaction)			ABCB1		D003520
CTD	affects(cotreatment)			ABCC1		D003520
CTD	affects(response to substance)			ABCC1		D003520
CTD	decreases(response to substance)			ABCC1		D003520
CTD	affects(cotreatment)			ABCG2		D003520
CTD	affects(response to substance)			ABCG2		D003520
CTD	increases(expression)			ABHD3		D003520
CTD	decreases(expression)			ACTB		D003520
CTD	affects(response to substance)			ADM		D003520
CTD	affects(response to substance)			AGL		D003520
CTD	affects(cotreatment)			ALAD		D003520
CTD	decreases(activity)			ALAD		D003520
CTD	affects(response to substance)			ALDH1A1		D003520
CTD	decreases(response to substance)			ALDH1A1		D003520
CTD	increases(expression)			ALDH1A1		D003520
CTD	increases(expression)			ALDH2		D003520
CTD	affects(response to substance)			ALDH3A1		D003520
CTD	decreases(expression)			ALOX5AP		D003520
CTD	affects(cotreatment)			AMFR		D003520
CTD	affects(response to substance)			AMFR		D003520
CTD	increases(expression)			ANGPT1		D003520
CTD	increases(expression)			ARHGDIB		D003520
CTD	increases(expression)			ARHGEF26		D003520
CTD	decreases(expression)			ASNS		D003520
CTD	decreases(expression)			ATF5		D003520
CTD	decreases(expression)			ATG3		D003520
CTD	increases(expression)			AXL		D003520
CTD	increases(expression)			B3GALNT2		D003520
CTD	affects(cotreatment)			BAG1		D003520
CTD	affects(expression)			BAG1		D003520
CTD	affects(cotreatment)			BBS4		D003520
CTD	affects(response to substance)			BBS4		D003520
CTD	decreases(activity)			BCHE		D003520
CTD	affects(cotreatment)			BCHE		D003520
CTD	decreases(expression)			BCHE		D003520
CTD	decreases(reaction)			BCL2		D003520
CTD	increases(activity)			BCL2		D003520
CTD	affects(cotreatment)			BCL2		D003520
CTD	decreases(expression)			BCL2		D003520
CTD	increases(expression)			BCL2		D003520
CTD	affects(cotreatment)			BCL2		D003520
CTD	affects(expression)			BCL2		D003520
CTD	decreases(expression)			BCL6		D003520
CTD	affects(response to substance)			BDH1		D003520
CTD	affects(cotreatment)			BECN1		D003520
CTD	affects(response to substance)			BECN1		D003520
CTD	decreases(expression)			BIK		D003520
CTD	decreases(expression)			BIRC3		D003520
CTD	decreases(expression)			BPI		D003520
CTD	affects(cotreatment)			BTG3		D003520
CTD	affects(response to substance)			BTG3		D003520
CTD	affects(cotreatment)			BUB3		D003520
CTD	affects(expression)			BUB3		D003520
CTD	decreases(expression)			C5ORF28		D003520
CTD	affects(cotreatment)			CA12		D003520
CTD	affects(response to substance)			CA12		D003520
CTD	decreases(expression)			CA2		D003520
CTD	decreases(expression)			CARS		D003520
CTD	decreases(expression)			CASP1		D003520
CTD	decreases(reaction)			CASP3		D003520
CTD	increases(activity)			CASP3		D003520
CTD	affects(cotreatment)			CASP3		D003520
CTD	increases(activity)			CASP3		D003520
CTD	decreases(response to substance)			CASP3		D003520
CTD	increases(activity)			CASP3		D003520
CTD	increases(cleavage)			CASP3		D003520
CTD	increases(expression)			CASP3		D003520
CTD	increases(activity)			CASP8		D003520
CTD	increases(cleavage)			CASP8		D003520
CTD	decreases(reaction)			CASP9		D003520
CTD	increases(activity)			CASP9		D003520
CTD	increases(activity)			CASP9		D003520
CTD	increases(cleavage)			CASP9		D003520
CTD	increases(expression)			CCIN		D003520
CTD	decreases(expression)			CCR8		D003520
CTD	decreases(expression)			CD69		D003520
CTD	increases(expression)			CD84		D003520
CTD	increases(expression)			CDKN1A		D003520
CTD	affects(cotreatment)			CDKN1B		D003520
CTD	affects(expression)			CDKN1B		D003520
CTD	decreases(expression)			CEBPB		D003520
CTD	increases(expression)			CEL		D003520
CTD	affects(response to substance)			CFI		D003520
CTD	decreases(expression)			CHAC1		D003520
CTD	decreases(expression)			CHAC1		D003520
CTD	affects(response to substance)			COCH		D003520
CTD	decreases(expression)			COX7A2		D003520
CTD	increases(expression)			CRABP2		D003520
CTD	affects(activity)			CSF2		D003520
CTD	decreases(expression)			CST7		D003520
CTD	decreases(expression)			CSTA		D003520
CTD	affects(cotreatment)			CTNNBIP1		D003520
CTD	affects(expression)			CTNNBIP1		D003520
CTD	affects(cotreatment)			CTNND2		D003520
CTD	affects(response to substance)			CTNND2		D003520
CTD	increases(expression)			CTSH		D003520
CTD	increases(expression)			CTSL		D003520
CTD	decreases(expression)			CYP1B1		D003520
CTD	decreases(activity)			CYP2B6		D003520
CTD	decreases(expression)			CYP2B6		D003520
CTD	increases(activity)			CYP2B6		D003520
CTD	increases(expression)			CYP2B6		D003520
CTD	affects(hydroxylation)			CYP2B6		D003520
CTD	affects(activity)			CYP2B6		D003520
CTD	affects(response to substance)			CYP2B6		D003520
CTD	increases(hydroxylation)			CYP2B6		D003520
CTD	increases(metabolic processing)			CYP2B6		D003520
CTD	increases(response to substance)			CYP2B6		D003520
CTD	increases(response to substance)			CYP2B6		D003520
CTD	affects(cotreatment)			CYP2B6		D003520
CTD	affects(expression)			CYP2B6		D003520
CTD	increases(reaction)			CYP2B6		D003520
CTD	increases(reaction)			CYP2B6		D003520
CTD	increases(response to substance)			CYP2B6		D003520
CTD	increases(activity)			CYP2C18		D003520
CTD	increases(response to substance)			CYP2C18		D003520
CTD	increases(reaction)			CYP2C18		D003520
CTD	decreases(metabolic processing)			CYP2C19		D003520
CTD	affects(activity)			CYP2C19		D003520
CTD	affects(response to substance)			CYP2C19		D003520
CTD	increases(metabolic processing)			CYP2C19		D003520
CTD	increases(activity)			CYP2C19		D003520
CTD	increases(activity)			CYP2C8		D003520
CTD	increases(metabolic processing)			CYP2C9		D003520
CTD	increases(response to substance)			CYP2C9		D003520
CTD	increases(activity)			CYP2C9		D003520
CTD	decreases(reaction)			CYP2C9		D003520
CTD	increases(metabolic processing)			CYP2D6		D003520
CTD	increases(activity)			CYP3A4		D003520
CTD	increases(expression)			CYP3A4		D003520
CTD	increases(expression)			CYP3A4		D003520
CTD	affects(cotreatment)			CYP3A4		D003520
CTD	affects(response to substance)			CYP3A4		D003520
CTD	affects(metabolic processing)			CYP3A4		D003520
CTD	increases(metabolic processing)			CYP3A4		D003520
CTD	affects(cotreatment)			CYP3A5		D003520
CTD	affects(response to substance)			CYP3A5		D003520
CTD	affects(metabolic processing)			CYP3A5		D003520
CTD	decreases(expression)			DDIT3		D003520
CTD	affects(response to substance)			DDIT4		D003520
CTD	increases(expression)			DLC1		D003520
CTD	increases(expression)			DNAJB1		D003520
CTD	increases(expression)			DNAJB4		D003520
CTD	increases(expression)			DNAJB6		D003520
CTD	decreases(degradation)			DNMT1		D003520
CTD	decreases(methylation)			DNMT1		D003520
CTD	increases(reaction)			DNMT1		D003520
CTD	increases(expression)			DNMT1		D003520
CTD	increases(expression)			DPYSL4		D003520
CTD	decreases(expression)			DUSP10		D003520
CTD	increases(expression)			DZIP1		D003520
CTD	affects(cotreatment)			E2F3		D003520
CTD	affects(response to substance)			E2F3		D003520
CTD	increases(expression)			EDA2R		D003520
CTD	increases(expression)			EDN1		D003520
CTD	increases(expression)			EDNRB		D003520
CTD	affects(cotreatment)			EGFR		D003520
CTD	affects(response to substance)			EGFR		D003520
CTD	increases(expression)			EGR1		D003520
CTD	affects(cotreatment)			EIF1AX		D003520
CTD	affects(expression)			EIF1AX		D003520
CTD	affects(cotreatment)			EIF4EBP1		D003520
CTD	affects(expression)			EIF4EBP1		D003520
CTD	affects(response to substance)			ELOVL2		D003520
CTD	increases(expression)			EMP1		D003520
CTD	increases(expression)			EMP3		D003520
CTD	decreases(expression)			EPB41L2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	affects(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	affects(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	affects(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	affects(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	affects(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB2		D003520
CTD	decreases(response to substance)			ERBB2		D003520
CTD	affects(cotreatment)			ERBB4		D003520
CTD	affects(response to substance)			ERBB4		D003520
CTD	increases(expression)			ERG		D003520
CTD	affects(cotreatment)			ESR1		D003520
CTD	increases(expression)			ESR1		D003520
CTD	affects(cotreatment)			ESR2		D003520
CTD	increases(expression)			ESR2		D003520
CTD	decreases(expression)			EVI2A		D003520
CTD	decreases(expression)			F3		D003520
CTD	decreases(expression)			FAM107B		D003520
CTD	affects(cotreatment)			FAS		D003520
CTD	decreases(expression)			FAS		D003520
CTD	affects(cotreatment)			FAS		D003520
CTD	increases(expression)			FAS		D003520
CTD	decreases(expression)			FAS		D003520
CTD	affects(cotreatment)			FASLG		D003520
CTD	increases(expression)			FASLG		D003520
CTD	affects(response to substance)			FKBP1B		D003520
CTD	increases(expression)			FKBPL		D003520
CTD	increases(expression)			FLNC		D003520
CTD	affects(response to substance)			FNDC3B		D003520
CTD	increases(expression)			FSCN1		D003520
CTD	increases(expression)			FSHB		D003520
CTD	increases(expression)			FYN		D003520
CTD	affects(response to substance)			GALC		D003520
CTD	affects(cotreatment)			GAMT		D003520
CTD	affects(response to substance)			GAMT		D003520
CTD	increases(expression)			GAS2		D003520
CTD	affects(cotreatment)			GFRA1		D003520
CTD	affects(response to substance)			GFRA1		D003520
CTD	decreases(expression)			GLOD4		D003520
CTD	increases(expression)			GLRB		D003520
CTD	increases(expression)			GLS		D003520
CTD	affects(response to substance)			GLS		D003520
CTD	increases(expression)			GNG12		D003520
CTD	increases(expression)			GPR137B		D003520
CTD	decreases(expression)			GPR18		D003520
CTD	increases(expression)			GPR20		D003520
CTD	decreases(expression)			GPT2		D003520
CTD	increases(expression)			GPX4		D003520
CTD	affects(cotreatment)			GSTA1		D003520
CTD	affects(metabolic processing)			GSTA1		D003520
CTD	affects(cotreatment)			GSTM1		D003520
CTD	affects(response to substance)			GSTM1		D003520
CTD	affects(cotreatment)			GSTP1		D003520
CTD	increases(response to substance)			GSTP1		D003520
CTD	affects(cotreatment)			GTF3C1		D003520
CTD	affects(expression)			GTF3C1		D003520
CTD	increases(expression)			HLA-F		D003520
CTD	increases(expression)			HMGCS1		D003520
CTD	decreases(expression)			HMOX1		D003520
CTD	increases(expression)			HNRNPK		D003520
CTD	affects(response to substance)			HOXA1		D003520
CTD	increases(expression)			HSPA1A		D003520
CTD	increases(expression)			HSPA1B		D003520
CTD	affects(response to substance)			HSPA2		D003520
CTD	increases(expression)			HSPA5		D003520
CTD	affects(response to substance)			HSPA8		D003520
CTD	increases(expression)			HSPH1		D003520
CTD	decreases(expression)			HYLS1		D003520
CTD	decreases(expression)			ICAM3		D003520
CTD	decreases(expression)			ID2		D003520
CTD	increases(expression)			IDI1		D003520
CTD	decreases(expression)			IER3		D003520
CTD	increases(expression)			IER5		D003520
CTD	decreases(expression)			IFRD1		D003520
CTD	affects(response to substance)			IGF2BP3		D003520
CTD	affects(response to substance)			IGFBP3		D003520
CTD	affects(cotreatment)			IGFBP4		D003520
CTD	affects(response to substance)			IGFBP4		D003520
CTD	decreases(expression)			IGFBP5		D003520
CTD	affects(response to substance)			IL1A		D003520
CTD	decreases(expression)			IL32		D003520
CTD	affects(cotreatment)			ILF3		D003520
CTD	affects(expression)			ILF3		D003520
CTD	affects(cotreatment)			IRS1		D003520
CTD	affects(expression)			IRS1		D003520
CTD	increases(expression)			ISG15		D003520
CTD	decreases(expression)			ISL2		D003520
CTD	decreases(expression)			KBTBD11		D003520
CTD	decreases(expression)			KCNQ4		D003520
CTD	decreases(degradation)			KDM1A		D003520
CTD	decreases(methylation)			KDM1A		D003520
CTD	increases(reaction)			KDM1A		D003520
CTD	increases(expression)			KDM1A		D003520
CTD	affects(cotreatment)			KDM4B		D003520
CTD	affects(response to substance)			KDM4B		D003520
CTD	affects(cotreatment)			KIAA1467		D003520
CTD	affects(response to substance)			KIAA1467		D003520
CTD	decreases(expression)			KIF21B		D003520
CTD	affects(cotreatment)			KIF3A		D003520
CTD	affects(response to substance)			KIF3A		D003520
CTD	decreases(response to substance)			KLF4		D003520
CTD	affects(response to substance)			KLF5		D003520
CTD	decreases(expression)			KRCC1		D003520
CTD	increases(expression)			KRT80		D003520
CTD	increases(expression)			LAMC2		D003520
CTD	affects(response to substance)			LDHB		D003520
CTD	increases(expression)			LGALS1		D003520
CTD	increases(expression)			LGALS7		D003520
CTD	affects(cotreatment)			LMNB1		D003520
CTD	decreases(expression)			LMNB1		D003520
CTD	decreases(expression)			LSG1		D003520
CTD	affects(response to substance)			MAGED1		D003520
CTD	affects(response to substance)			MAGED4B		D003520
CTD	increases(expression)			MAOA		D003520
CTD	affects(cotreatment)			MAPK14		D003520
CTD	affects(expression)			MAPK14		D003520
CTD	affects(cotreatment)			MAPT		D003520
CTD	affects(response to substance)			MAPT		D003520
CTD	increases(expression)			MARCKS		D003520
CTD	decreases(expression)			MDFIC		D003520
CTD	affects(cotreatment)			MED13L		D003520
CTD	affects(response to substance)			MED13L		D003520
CTD	affects(cotreatment)			MELK		D003520
CTD	affects(response to substance)			MELK		D003520
CTD	affects(cotreatment)			METRN		D003520
CTD	affects(response to substance)			METRN		D003520
CTD	decreases(expression)			MGMT		D003520
CTD	decreases(response to substance)			MGMT		D003520
CTD	affects(response to substance)			MPC2		D003520
CTD	increases(expression)			MR1		D003520
CTD	decreases(expression)			MS4A3		D003520
CTD	decreases(expression)			MTHFD2		D003520
CTD	decreases(expression)			MX2		D003520
CTD	affects(response to substance)			MXI1		D003520
CTD	affects(response to substance)			MYH10		D003520
CTD	affects(cotreatment)			NAIP		D003520
CTD	affects(expression)			NAIP		D003520
CTD	increases(expression)			NANOS1		D003520
CTD	decreases(expression)			NCOA7		D003520
CTD	increases(expression)			NETO2		D003520
CTD	decreases(expression)			NFE2L3		D003520
CTD	affects(response to substance)			NID1		D003520
CTD	affects(cotreatment)			NKAIN1		D003520
CTD	affects(response to substance)			NKAIN1		D003520
CTD	increases(expression)			NPPB		D003520
CTD	decreases(expression)			NPRL2		D003520
CTD	affects(binding)			NR1I2		D003520
CTD	increases(activity)			NR1I2		D003520
CTD	increases(activity)			NR1I2		D003520
CTD	increases(expression)			NR1I2		D003520
CTD	increases(activity)			NR1I2		D003520
CTD	increases(expression)			NR1I2		D003520
CTD	increases(reaction)			NR1I2		D003520
CTD	increases(activity)			NR1I3		D003520
CTD	increases(expression)			NR1I3		D003520
CTD	increases(expression)			NRG1		D003520
CTD	increases(expression)			NT5C2		D003520
CTD	affects(response to substance)			OPN3		D003520
CTD	decreases(expression)			P2RY2		D003520
CTD	decreases(expression)			PAIP1		D003520
CTD	increases(expression)			PALM2-AKAP2		D003520
CTD	decreases(expression)			PARD3		D003520
CTD	affects(cotreatment)			PARP1		D003520
CTD	decreases(expression)			PARP1		D003520
CTD	increases(cleavage)			PARP1		D003520
CTD	decreases(expression)			PDCD4		D003520
CTD	decreases(expression)			PELI1		D003520
CTD	increases(expression)			PHLDA2		D003520
CTD	increases(expression)			PLAU		D003520
CTD	affects(cotreatment)			PLOD1		D003520
CTD	affects(expression)			PLOD1		D003520
CTD	affects(cotreatment)			PLOD3		D003520
CTD	affects(expression)			PLOD3		D003520
CTD	increases(expression)			POLM		D003520
CTD	increases(reaction)			POR		D003520
CTD	increases(response to substance)			POR		D003520
CTD	increases(reaction)			POR		D003520
CTD	increases(response to substance)			POR		D003520
CTD	increases(expression)			PROCR		D003520
CTD	affects(response to substance)			PRSS3		D003520
CTD	decreases(expression)			PRTN3		D003520
CTD	increases(expression)			PSMA5		D003520
CTD	affects(response to substance)			PTGS2		D003520
CTD	increases(expression)			RAMP1		D003520
CTD	affects(cotreatment)			RAMP1		D003520
CTD	affects(response to substance)			RAMP1		D003520
CTD	increases(expression)			RBPMS		D003520
CTD	increases(expression)			RIPPLY3		D003520
CTD	decreases(expression)			RNASE2		D003520
CTD	affects(response to substance)			RPS6KA2		D003520
CTD	decreases(expression)			RRAGA		D003520
CTD	increases(expression)			RRAS2		D003520
CTD	affects(cotreatment)			RRM2		D003520
CTD	affects(response to substance)			RRM2		D003520
CTD	increases(expression)			RRM2B		D003520
CTD	increases(expression)			RTEL1		D003520
CTD	decreases(expression)			RUNX3		D003520
CTD	decreases(expression)			S100P		D003520
CTD	affects(response to substance)			S100P		D003520
CTD	affects(response to substance)			SALL1		D003520
CTD	affects(cotreatment)			SCUBE2		D003520
CTD	affects(response to substance)			SCUBE2		D003520
CTD	decreases(expression)			SESN2		D003520
CTD	increases(expression)			SFN		D003520
CTD	affects(response to substance)			SGCE		D003520
CTD	decreases(expression)			SGK1		D003520
CTD	increases(expression)			SLC2A6		D003520
CTD	decreases(expression)			SLC3A2		D003520
CTD	decreases(expression)			SLC43A1		D003520
CTD	affects(expression)			SLC7A11		D003520
CTD	decreases(expression)			SLC7A11		D003520
CTD	decreases(expression)			SLIT1		D003520
CTD	affects(response to substance)			SOAT1		D003520
CTD	increases(expression)			SPARC		D003520
CTD	affects(response to substance)			SPP1		D003520
CTD	affects(cotreatment)			SRM		D003520
CTD	affects(expression)			SRM		D003520
CTD	affects(cotreatment)			ST14		D003520
CTD	affects(expression)			ST14		D003520
CTD	affects(cotreatment)			STK39		D003520
CTD	affects(expression)			STK39		D003520
CTD	increases(expression)			STMN3		D003520
CTD	increases(expression)			STOM		D003520
CTD	increases(expression)			TAP1		D003520
CTD	decreases(expression)			TEX30		D003520
CTD	affects(cotreatment)			THNSL2		D003520
CTD	affects(response to substance)			THNSL2		D003520
CTD	increases(expression)			TM4SF1		D003520
CTD	decreases(expression)			TM6SF1		D003520
CTD	affects(response to substance)			TMEFF1		D003520
CTD	increases(expression)			TNFAIP3		D003520
CTD	increases(expression)			TNFRSF14		D003520
CTD	increases(expression)			TNFSF9		D003520
CTD	increases(expression)			TNNI3		D003520
CTD	affects(cotreatment)			TOP2A		D003520
CTD	affects(response to substance)			TOP2A		D003520
CTD	affects(cotreatment)			TOP2A		D003520
CTD	affects(response to substance)			TOP2A		D003520
CTD	increases(activity)			TP53		D003520
CTD	increases(mutagenesis)			TP53		D003520
CTD	affects(response to substance)			TP53		D003520
CTD	decreases(expression)			TPD52		D003520
CTD	affects(response to substance)			TPM1		D003520
CTD	decreases(expression)			TRIB3		D003520
CTD	increases(expression)			TUBA4A		D003520
CTD	affects(cotreatment)			TYMP		D003520
CTD	increases(expression)			TYMP		D003520
CTD	decreases(expression)			UCP1		D003520
CTD	increases(expression)			USP36		D003520
CTD	decreases(expression)			VEGFA		D003520
CTD	decreases(expression)			VLDLR		D003520
CTD	decreases(expression)			XAF1		D003520
CTD	affects(response to substance)			ZIC1		D003520
CTD	affects(cotreatment)			ZNF552		D003520
CTD	affects(response to substance)			ZNF552		D003520
CTD	decreases(expression)			ZNF671		D003520
PubChem	Potency	uM	0.006	CBX1	-	GI(Protien) :
PubChem	Potency	uM	17.783	EHMT2	-	GI(Protien) :
ChEMBL	Potency	nM	6.000	CBX1	-	Target : CHEMBL1741193
ChEMBL	Inhibition	-		CYP1A2	-	Target : CHEMBL3356
ChEMBL	Inhibition	-		CYP2C19	-	Target : CHEMBL3622
ChEMBL	Inhibition	-		CYP2C9	-	Target : CHEMBL3397
ChEMBL	Inhibition	-		CYP2D6	-	Target : CHEMBL289
ChEMBL	Inhibition	-		CYP3A4	-	Target : CHEMBL340
ChEMBL	Inhibition	-		CYP3A4	-	Target : CHEMBL340
ChEMBL	Potency	nM	17782.800	EHMT2	-	Target : CHEMBL6032

Download gene sets

gmt, text, Detailed text